The biotechnology market in Brazil is expected to reach a projected revenue of US$ 69,140.3 million by 2030. A compound annual growth rate of 14.2% is expected of Brazil biotechnology market from 2024 to 2030. In terms of segment, health was the largest revenue generating application in 2023. Bioinformatics is the most lucrative application segment registering the fastest growth during the forecast period. In Latin America, Brazil biotechnology market is projected to lead the regional market in terms of revenue in 2030.
The biotechnology market in Brazil has seen enormous activity this year in both the areas of industrial biotechnology and healthcare. In a recent webinar that discussed the latest results of the annual Scientific American Worldview report, panelists were especially excited by the partnering opportunities in Brazil. Mike May, Editorial Director, Scientific American Worldview, commented, “Brazil is, as a country, like a master of partnering. They partner in the country between industry and government. They partner outside the country with industry and industry in other places. They have huge networks of partnering. They’re bringing industries in from other countries to help them with things where maybe they don’t have the technology… So you know, it’s like they’re finding creative ways to deal with some of the challenges they have that, say, the United States doesn’t have.”
Building on this movement, Keter Biotech have partnered to of the best global bio companies to supply and suport the market in Latin America’s rapidly-growing biotechnology sector. Specially with the focus Health, well-being and beauty/cosmetics industries.